Influenza A antibody Avian antibody H5N1 antibody Hemagglutinin (HA) (IN) antibody Control peptide

General information
 

Name:
Influenza A antibody Avian antibody H5N1 antibody Hemagglutinin (HA) (IN) antibody Control peptide
Size:
50 μg
Catalog no:
X2651B
Price:
345 EUR
 

Additional extra details
 

  • Category

    Proteins & Peptides

    Long description

    Influenza virus is a single-stranded RNA virus, segmented, 70nm in diameter and enveloped. Strains are described by geographic origin, strain number, year of isolation and hemagglutination (H) and neuraminidase (N) antigens.

    Antibody come from

    Synthetic peptide derived from the C terminal region of the ASAH1 protein.

  • Other description

    Provided as solution in phosphate buffered saline with 0.08% sodium azide. Purified

    Clone

    not specified

    Antigen-antibody binding interaction

    Influenza A antibody Avian antibody H5N1 antibody Hemagglutinin (HA) (IN) antibody Control peptide

  • Antibody is raised in

    see techfile

    Antibody's reacts with

    see techfile

    Antibody's reacts with these species

    This antibody doesn't cross react with other species

  • Antibody's specificity

    No Data Available

    Application

    ELISA, Antibody Blocking

    Antibody's suited for

    Antibody can be used for Western blotting (1-5 µg/ml) and Immunohistochemistry on paraffin-embedded tissues (10 µg/ml). Optimal concentration should be evaluated by serial dilutions.

  • Storage

    -20ºC

    Relevant references

    1. Park, J.H., et al. 'Acid ceramidase and human disease.' Biochim Biophys Acta 2006; 1758:2133-2138._x000B__x000B_2. Zeidan, Y.H., et al. 'Acid ceramidase but not acid sphingomyelinase is required for tumor necrosis factor-{alpha}-induced PGE2 production.' J. Biol. Chem. 2006; 281:24695-24703._x000B__x000B_3. Shtraizent, N., et al. 'Autoproteolytic cleavage and activation of human acid ceramidase.' J. Biol. Chem. 2008; 283:11253-11259.

    Protein number

    see ncbi

  • Warnings

    This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals. This datasheet is as accurate as reasonably achievable, but Nordic-MUbio accepts no liability for any inaccuracies or omissions in this information.

    Tissue

    control

    Virus

    influenza

  • Properties

    If you buy Antibodies supplied by nordc they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.

    Description

    Isotype or positive controls by peptides, antibodies and deactivated samples.Influenza A and B H1N1 H3N2 Hemagglutinin-nucleoprotein recombinant proteins, peptides and antibodies detect a virus commonly known as "the flu". Influenza is an infectious disease caused by an influenza virus. Symptoms can be mild to severe. The most common symptoms include a high fever, runny nose, sore throat, muscle pains, headache, coughing, and feeling tired. These symptoms typically begin two days after exposure to the virus and most last less than a week. The cough, however, may last for more than two weeks. In children, there may be nausea and vomiting, but these are not common in adults.Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.

    French translation

    anticorps